A new approach in underwriting high-cost drugs
In recent years, private drug plan sponsors have been faced with a serious issue: an increase in the number of covered individuals claiming very high-cost…
- By: Jonathan Bohm
- December 6, 2013 September 13, 2019
- 10:39